Loading clinical trials...
Loading clinical trials...
Novel Desensitization Protocol With Proteasome Inhibitor and Costimulation Blockade for Highly Sensitized Patients to Allow for Successful Kidney Transplantation. A Pilot Study.
Conditions
Interventions
Belatacept Injection
Locations
1
United States
University of Chicago
Chicago, Illinois, United States
Start Date
May 1, 2022
Primary Completion Date
September 12, 2025
Completion Date
September 12, 2025
Last Updated
December 9, 2025
NCT05753930
NCT04128189
NCT07157397
NCT04870437
NCT07415421
NCT06958796
Lead Sponsor
University of Chicago
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions